ARCHIVES

June issue of Business & Regulatory Report included.

This article is from The Cancer Letter archive.

Vol. 30 No. 27 | July 2, 2004

Download PDF Visit The Full Archive

Related Articles

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.

November 28, 2003

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Young Investigator Grants Available

July 8, 1977